Dom Dolla's rise from Melbourne club favourite to global electronic music phenomenon has culminated in sold-out stadium shows, more than...

A decade ago, anyone wanting to connect with the people shaping the future of psychedelic medicine needed more than curiosity...

Australia's psychology profession is pushing back against new psychedelic-assisted therapy training requirements, arguing that the changes exclude the majority of...

As workforce shortages deepen across the country, Australia faces an uncomfortable question: why are we importing healthcare workers to fill...

Australia's emerging psychedelic medicine sector is warning that proposed federal tax reforms could undermine the country's ability to attract investment...

Five years ago, psychedelic stocks were among the hottest stories in biotechnology. Investors poured money into companies developing treatments based...

Australia's medicines regulator has signalled it will reject a proposal to allow psilocybin-assisted therapy for end-of-life distress, raising fresh questions...

Australian pharmaceutical and psychedelic medicines company Bioxyne has announced the appointment of experienced investor and business executive Edward Myer as...

One of the biggest questions surrounding psychedelic medicine has never been whether psilocybin can produce rapid antidepressant effects. The real...

In Australia, psychedelic-assisted therapy has been one of the most tightly controlled medical innovations in the world. Since 2023, MDMA...